Russell Investments Group
IPSC icon

Russell Investments Group’s Century Therapeutics IPSC Stock Holding History

Russell Investments Group’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.1K Buy
+9,855
New +$22.5K ﹤0.01% 3783
2024
Q3 		– Sell
-5,842
Closed -$14.9K – 3744
2024
Q2 		$14.9K Buy
5,842
+2,990
+105% +$9.45K ﹤0.01% 2995
2024
Q1 		$11.9K Hold
2,852
– – ﹤0.01% 2829
2023
Q4 		$9.47K Buy
2,852
+2,370
+492% +$4.32K ﹤0.01% 2830
2023
Q3 		$964 Sell
482
-1,893
-80% -$5.04K ﹤0.01% 3340
2023
Q2 		$7.5K Hold
2,375
– – ﹤0.01% 3024
2023
Q1 		$8.24K Hold
2,375
– – ﹤0.01% 2909
2022
Q4 		$12.2K Hold
2,375
– – ﹤0.01% 2837
2022
Q3 		$23K Sell
2,375
-933
-28% -$9.8K ﹤0.01% 2801
2022
Q2 		$27K Buy
+3,308
New +$32.4K ﹤0.01% 2774

Other funds holding IPSC

RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Commodore Capital
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VR Adviser
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Russell Investments Group's IPSC Position: Q2 2026 in Review

Russell Investments Group opened a new position in Century Therapeutics (IPSC) in Q2 2026: 9,855 shares worth $24.1K. The stake represents ﹤0.01% of the portfolio and ranks #3783 among its holdings. This is a return to the name: Russell Investments Group previously reported a position in IPSC as recently as Q2 2024.

Russell Investments Group first reported a position in IPSC in Q2 2022 and has held it in 10 quarters since. The position peaked at $27K in Q2 2022. 100 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Russell Investments Group held 9,855 shares of Century Therapeutics worth $24.1K as of Q2 2026.
  • Century Therapeutics was a new Russell Investments Group position in Q2 2026.
  • Century Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3783 holding.
  • Russell Investments Group first reported a position in Century Therapeutics in Q2 2022 and has held it in 10 quarters since.
  • Russell Investments Group's Century Therapeutics position peaked at $27K in Q2 2022.
  • 100 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.